US Drug Recall Register
Class II · Moderate risk Terminated Initiated Sep 20, 2018 (8 years ago)

Meropenem for Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of assurance of sterility: loss of container integrity.

What was recalled

Meropenem for Injection, USA (I.V.), 1 gram/vial, 25 vials per carton, Sterile, Rx Only, Manufactured for: Hospira, Inc., Lake Forest, IL 60045, USA. NDC carton: 0409-3506-01; NDC vial: 0409-3506-11

Recalling firm
Pfizer Inc.
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0095-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Meropenem recalls

See all
Class II · Moderate risk Terminated

Meropenem

Reason Lack of sterility assurance

Sentara Infusion Services D-0303-2023
Class II · Moderate risk Terminated

Meropenem 2 grams in 100 mL 0.9% NS bag

Reason Lack of Sterility Assurance

Baptist Health Medical Towers Pharmacy and Infusion Services D-0929-2016
Class II · Moderate risk Terminated

MEROPENEM in NS

Reason Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Sentara Enterprises D-0611-2016